CORCEPT THERAPEUTICS INC (CORT) earnings date, results and what the price requires
Nasdaq · SEC CIK 0001088856 · SEC filings checked Oct 17, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 29, 2026 | $256.1M | $43.0M | $0.36 | Filing |
| Mar 31, 2026 | Apr 30, 2026 | $164.9M | $-31.8M | $-0.30 | Filing |
| Dec 31, 2025 | Feb 24, 2026 | $202.1M | $24.3M | $0.20 | Filing |
| Sep 30, 2025 | Nov 4, 2025 | $207.6M | $19.7M | $0.16 | Filing |
| Jun 30, 2025 | Jul 31, 2025 | $194.4M | $35.1M | $0.29 | Filing |
| Mar 31, 2025 | May 5, 2025 | $157.2M | $20.5M | $0.17 | Filing |
| Dec 31, 2024 | Feb 26, 2025 | $181.9M | $30.7M | $0.25 | Filing |
| Sep 30, 2024 | Oct 30, 2024 | $182.5M | $47.2M | $0.41 | Filing |
What would CORCEPT THERAPEUTICS INC have to report for its valuation to change?
At $113.37, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about 87.3% a year, to $9.69. On that path the next quarter needs diluted EPS near $0.30, against $0.16 in the quarter ended Sep 30, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | 87.3% | 87.3% |
| EPS needed in final year | $9.69 | $9.69 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. CORT goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.